Immuron (IMRN) furnishes Form 6-K with AusBiotech 2025 presentation

Immuron Limited furnished a Form 6-K to provide investors with an Australian Securities Exchange announcement dated October 21, 2025.

Accepted by SEC EDGAR 10/20/2025 - 09:20 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Immuron Limited furnished a Form 6-K to provide investors with an Australian Securities Exchange announcement dated October 21, 2025. The filing attaches Exhibit 99.1 titled “Presentation to AusBiotech Invest 2025 Conference.”

The material is furnished, not filed, under the Exchange Act and is not incorporated by reference into other securities filings unless specifically referenced. This update primarily shares the presentation made available to the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Immuron (IMRN) disclose in this Form 6-K?

Immuron furnished an ASX announcement attaching Exhibit 99.1, titled “Presentation to AusBiotech Invest 2025 Conference.”

What is included as Exhibit 99.1 for IMRN?

Exhibit 99.1 is the “Presentation to AusBiotech Invest 2025 Conference.”

When was the ASX announcement referenced by IMRN made?

The announcement was dated October 21, 2025.

Is this 6-K considered filed or furnished?

It is furnished, not filed, under the Exchange Act.

Will the 6-K be incorporated by reference into other filings?

It will not be incorporated by reference unless expressly stated by specific reference.

Does the 6-K contain financial results for IMRN?

No. It provides a presentation attachment and related disclosure only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of October 2025

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐       No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 21, 2025 titled:

			-	Presentation to AusBiotech Invest 2025 Conference
			-

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

1

EXHIBITS

Exhibit Number		Description
99.1		Presentation to AusBiotech Invest 2025 Conference

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: October 21, 2025	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

3